Financial Times

News

Meet us at BIO-Europe 2024

Excited to be attending BIO-Europe in Stockholm, Sweden from November 4–6, 2024! Looking forward to connecting and exchanging insights. See you there!

8th International Symposium on Phospholipids in Pharmaceutical Research

I had the pleasure of speaking at the 8th International Symposium on Phospholipids in Pharmaceutical Research last week, where there was even a dedicated session on Tetraether lipids—an exciting development for a field that’s gaining momentum.

The event was full of insightful presentations and engaging discussions, and it was a privilege to be part of it.

A big thank you to everyone who made the event a success! Looking forward to more exciting developments in the future.

Read more

NovoArc’s Innovations Impress Minister Polaschek

We had the honor of welcoming Federal Minister Polaschek to our company. During his visit, he showed great interest in our technology and was impressed by our innovative approach.

The Minister toured our company premises, and we engaged in an exciting discussion about the future of biotechnology in Austria. His positive feedback reinforces our mission to develop groundbreaking solutions.

"I am very pleased with the impressive progress NovoArc has made. They are a prime example of a successful academic spin-off," said Federal Minister Polaschek.

Thank you, Minister, for your support and the inspiring conversations! We look forward to advancing our innovations and bringing Austria to the forefront of the biotech industry.

New publication – improved transfection efficiency of mRNA-LNP

New publication - improved transfection efficiency of mRNA-LNPs

We're thrilled to announce that our latest research has been published online in the European Journal of Pharmaceutics and Biopharmaceutics!

In cooperation with TU Wien our team at NovoArc was able to demonstrate an innovative approach to enhance transfection efficiency for mRNA in in vitro studies. This advancement holds great promise for the future of vaccination and gene therapy, opening new pathways for medical treatments and patient care.

Stay tuned for more updates as we will be conducting in vivo studies very soon.

Read more

mRNA Health Conference

Enjoying inspiring talks and fruitful discussions at the 11th mRNA Health Conference in Berlin.

Advisory Board with Experts from Science and Industry

Super excited and proud to announce our newly formed advisory board with experts from science and industry!

Prof. Michael Freissmuth - Head of Pharmacology Medical University Vienna
Dr. Andreas Wagner - Head of Liposome Technology Polymun Scientific
Mag. Schmutz Helmut - Serial Entrepreneur and Investor in Biotech/Pharma
Prof. Hartmut J. Ehrlich, Prof. Dr., M.D. - Former CEO Abivax

Previous Next